Начало › Рак (всички видове) › Флорида › Tampa
Клинични проучвания за Рак (всички видове) в Tampa, FL
39 проучвания за Рак (всички видове) търсят участници в обекти в и около Tampa (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Набиране на участнициФаза 2/3
- Moffitt Cancer Center /ID# 276785, Tampa
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Набиране на участнициФаза 1
- Moffit Cancer Center, Tampa
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Набиране на участнициФаза 1
- Moffitt Cancer Center /ID# 279068, Tampa
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Набиране на участнициНаблюдателно проучване
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Набиране на участнициНаблюдателно проучване
- Moffitt Cancer Center, Tampa
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Набиране на участнициФаза 1
- Moffit Cancer center, Tampa
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Набиране на участнициФаза 3
- Moffitt Cancer Center /ID# 279732, Tampa
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Набиране на участнициФаза 1/2
- Moffitt Cancer Center and Research Institute, Tampa
Prospective Study to Assess a Diagnostic Aid for Cancer
Набиране на участнициНаблюдателно проучване
- Avita Clinical Research, Tampa
Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
Набиране на участнициНаблюдателно проучване
- Moffitt Cancer Center, Tampa
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Набиране на участнициФаза 2/3
- USF Health Morsani Center for Advanced Healthcare, Tampa
- H. Lee Moffitt Cancer Center and Research Institute University of South Florida, Tampa
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Набиране на участнициФаза 2
- University of South Florida, Department of Psychiatry and Behavioral Neuroscience, Tampa
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Набиране на участнициФаза 1/2
- Moffitt Cancer Center, Tampa
Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)
Набиране на участнициЗдравите доброволци са добре дошли
- Moffitt Cancer Center, Tampa
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1
- Moffitt Cancer Center, Tampa
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Набиране на участнициФаза 1
- Moffitt Cancer Center, Tampa
Project: Every Child for Younger Patients With Cancer
Набиране на участнициНаблюдателно проучване
- Tampa General Hospital, Tampa
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Набиране на участнициФаза 3
- Moffitt Cancer Center, Tampa
Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
Набиране на участнициЗдравите доброволци са добре дошли
- Moffitt Cancer Center, Tampa
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Набиране на участнициФаза 1/2
- Moffitt Cancer Center /ID# 272628, Tampa
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Набиране на участнициФаза 2
- Moffitt Cancer Center /ID# 274372, Tampa
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1/2
- Moffitt Cancer Center, Tampa
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Набиране на участнициФаза 2
- Moffitt Cancer Center, Tampa
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Набиране на участнициФаза 1/2
- H Lee Moffitt Cancer Center and Research Institute, Tampa
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Набиране на участнициФаза 1/2
- Moffitt Cancer Center, Tampa
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Набиране на участнициФаза 1/2
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Набиране на участнициФаза 1/2
- Moffitt Cancer Center and Research Institute, Tampa
Galleri® in the Medicare Population.
Набиране на участнициЗдравите доброволци са добре дошли
- USF Morsani Center for Advanced Healthcare, Tampa
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- Moffitt Cancer Center, Tampa
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Набиране на участнициФаза 2
- H. Lee Moffitt Cancer Center and Research Institute, Tampa
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
Набиране на участнициФаза 2
- Moffitt Cancer Center, Tampa
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Набиране на участнициФаза 1
- Moffitt Cancer Center, Tampa
Beat Childhood Cancer Specimen Banking and Data Registry
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- St. Joseph's Children's Hospital, Tampa
Caris Biorepository Research Protocol
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- The University of South Florida, Tampa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набиране на участнициНаблюдателно проучване
- Massive Bio SYNERGY-AI site, Tampa
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
Набиране на участници
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Набиране на участнициФаза 1/2
- Moffitt Cancer Center, Tampa
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Набиране на участници
- Moffitt Cancer Center - McKinley Campus, Tampa
- Moffitt Cancer Center, Magnolia Campus, Tampa
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Набиране на участнициФаза 1/2
- Moffitt Cancer Center, Tampa
Проучвания за Рак (всички видове) в други градове
- Houston, TX121 проучвания
- New York City, NY109 проучвания
- Boston, MA85 проучвания
- Los Angeles, CA74 проучвания
- Nashville, TN65 проучвания
- Philadelphia, PA59 проучвания
- Washington, DC58 проучвания
- Durham, NC58 проучвания
- Chicago, IL51 проучвания
- Atlanta, GA49 проучвания
- Seattle, WA49 проучвания
- Arlington, VA48 проучвания
Други проучвания в Tampa
- Рак на белия дроб с недребноклетъчен тип51 проучвания
- Рак на гърдата43 проучвания
- Колоректален рак34 проучвания
- Остра миелоидна левкемия29 проучвания
- Метастатичен рак29 проучвания
- Рак на белия дроб29 проучвания
- Рак на панкреаса26 проучвания
- Рак на яйчниците21 проучвания
- Меланом19 проучвания
- Миелодиспластични синдроми19 проучвания
- Рак на простатата18 проучвания
- Сърдечна недостатъчност18 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.